83.80

0.54% 0.45

After Hours: 83.80

Boston Scientific Corp (BSX)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split

Boston Scientific Corp stock is traded at $83.80, with a volume of 3.67M. It is up +0.54% in the last 24 hours and up +2.46% over the past month. Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.

Previous Close:

$83.35

Open:

$83.32

24h Volume:

3.67M

Relative Volume:

0.70

Market Cap:

$122.39B

Revenue:

$15.23B

Net Income/Loss:

$1.83B

P/E Ratio:

102.20

EPS:

0.82

Net Cash Flow:

$1.69B

1W Performance:

-0.24%

1M Performance:

+2.46%

6M Performance:

+22.35%

1Y Performance:

+58.71%

1-Day Range:

$82.92

$83.86

1-Week Range:

$82.59

$84.07

52-Week Range:

$48.35

$84.89

Boston Scientific Corp Stock (BSX) Company Profile

Name

Boston Scientific Corp

Sector

Healthcare (1190)

Industry

Medical Devices (154)

Phone

508-683-4000

Address

300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA

Employee

48,000

Twitter

@bostonsci

Next Earnings Date

2024-10-24

Latest SEC Filings

BSX's Discussions on Twitter

Boston Scientific Corp Stock (BSX) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Feb-01-24	Upgrade	Mizuho	Neutral → Buy
Jul-19-23	Initiated	Robert W. Baird	Outperform
Jun-30-23	Initiated	CL King	Buy
May-30-23	Resumed	Morgan Stanley	Overweight
Mar-29-23	Initiated	UBS	Buy
Dec-22-22	Initiated	Mizuho	Neutral
Dec-20-22	Resumed	Citigroup	Buy
Oct-18-22	Initiated	Barclays	Overweight
Oct-12-22	Initiated	Jefferies	Buy
Jul-06-22	Initiated	Wolfe Research	Outperform
May-27-22	Upgrade	Needham	Hold → Buy
Apr-13-22	Resumed	Truist	Buy
Mar-02-22	Resumed	BofA Securities	Buy
Dec-10-21	Initiated	RBC Capital Mkts	Outperform
May-26-21	Downgrade	Needham	Buy → Hold
May-25-21	Initiated	Barclays	Overweight
Apr-15-21	Initiated	Atlantic Equities	Overweight
Sep-17-20	Initiated	Truist	Buy
Sep-11-20	Initiated	Wolfe Research	Peer Perform
Apr-22-20	Downgrade	SVB Leerink	Outperform → Mkt Perform
Apr-01-20	Upgrade	Goldman	Neutral → Buy
Mar-05-20	Initiated	Citigroup	Buy
Feb-13-20	Initiated	Goldman	Neutral
Feb-06-20	Resumed	BTIG Research	Buy
Dec-30-19	Reiterated	Cowen	Outperform
Dec-19-19	Downgrade	Needham	Strong Buy → Buy
Sep-05-19	Resumed	JP Morgan	Overweight
Sep-03-19	Resumed	Barclays	Overweight
May-13-19	Upgrade	Evercore ISI	In-line → Outperform
Nov-28-18	Initiated	UBS	Buy
Oct-16-18	Initiated	Barclays	Overweight
Oct-02-18	Reiterated	Morgan Stanley	Overweight
Sep-07-18	Reiterated	Needham	Strong Buy
Sep-04-18	Upgrade	Jefferies	Hold → Buy
Jul-06-18	Reiterated	Needham	Strong Buy
Jun-27-18	Initiated	Bernstein	Outperform
Apr-26-18	Reiterated	Needham	Strong Buy

View All

Boston Scientific Corp Stock (BSX) Latest News

05:33 AM

Bioabsorbable Sutures Market Future Scenario – W. L. Gore & Associates, Zeus Industrial Products, B. Braun Melsungen AG, Boston Scientific Corporation – Cauverynews - Cauverynews

05:33 AM

05:12 AM

Zacks.com featured highlights General Motors, Boston Scientific and Assurant - Yahoo Finance

05:12 AM

04:53 AM

Boston Scientific Corporation (BSX) Gains 44% YTD as Farapulse Launch Drives 17% Q2 Growth - Insider Monkey

04:53 AM

04:50 AM

Boston Scientific’s Farapulse PFA system receives approval in Japan - Medical Device Network

04:50 AM

Sep 28, 2024

AQR Capital Management LLC Reduces Holdings in Boston Scientific Co. (NYSE:BSX) - MarketBeat

Sep 28, 2024

Sep 27, 2024

Boston Scientific shares hold as analyst reiterates buy rating - Investing.com

Sep 27, 2024

Boston Scientific gains Japan approval for AF treatment system By Investing.com - Investing.com Canada

Sep 27, 2024

Boston Scientific wins Farapulse PFA approval in Japan - Mass Device

Sep 27, 2024

Boston Scientific gains Japan approval for AF treatment system - Investing.com

Sep 27, 2024

Boston Scientific Receives Japanese Regulatory Approval for the FARAPULSE™ Pulsed Field Ablation System - Quantisnow

Sep 27, 2024

Sep 26, 2024

Boston Scientific (BSX) Stock Declines While Market Improves: Some Information for Investors - Yahoo Finance

Sep 26, 2024

Hysteroscopy Procedures Market Global Insights, Trends and Huge Business Opportunities 2024-2033 | B. Braun Melsungen AG, Boston Scientific Corp., CooperCompanies, Delmont Imaging, Hologic – Cauverynews - Cauverynews

Sep 26, 2024

Sep 25, 2024

Zacks Industry Outlook Highlights Boston Scientific, Baxter International, Haemonetics and Phibro Animal Health - Yahoo Finance

Sep 25, 2024

Sep 24, 2024

Boston Scientific Corp. stock outperforms competitors despite losses on the day - MarketWatch

Sep 24, 2024

Slowing Rates Of Return At Boston Scientific (NYSE:BSX) Leave Little Room For Excitement - Simply Wall St

Sep 24, 2024

Farallon Capital Management LLC Sells 487,500 Shares of Boston Scientific Co. (NYSE:BSX) - Defense World

Sep 24, 2024

BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp Trims Stock Position in Boston Scientific Co. (NYSE:BSX) - Defense World

Sep 24, 2024

Aristeia Capital L.L.C. Acquires 8,079 Shares of Dave & Buster’s Entertainment Inc (NASDAQ:PLAY) - Defense World

Sep 24, 2024

The Boston Beer Company, Inc. (NYSE:SAM) Shares Acquired by Canada Pension Plan Investment Board - Defense World

Sep 24, 2024

4 Medical Product Stocks to Buy From a Prospective Industry - Yahoo Finance

Sep 24, 2024